Integra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary

Integra LifeSciences Holdings

Yesterday 14:31

Integra LifeSciences Holdings Corporation IART.OQ reported quarterly adjusted earnings of 59 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 54 cents.  The mean expectation of eleven analysts for the quarter was for earnings of 56 cents per share. Wall Street expected results to range from 54 cents to 59 cents per share.
Revenue rose 2.3% to $411.18 million from a year ago; analysts expected $414.12 million. 
Integra LifeSciences Holdings Corporation's reported EPS for the quarter was 19 cents​.
The company reported quarterly net income of $14.85 million.
Integra LifeSciences Holdings Corporation shares had fallen by 18.1% this quarter and gained 7.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.4% in the last three months.​ 
In the last 30 days, three analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."
Wall Street's median 12-month price target for Integra LifeSciences Holdings Corporation is $15.00, about 11.1% above its last closing price of $13.33
This summary was machine generated from LSEG data October 21 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Sep. 30 2026 
0.56
0.59
Beat
Jun. 30 2026 
0.48
0.56
Beat
Mar. 31 2026 
0.40
0.54
Beat
Dec. 31 2025 
0.80
0.83
Beat